DOTA-GPC3 targeting peptide 2 is an RDC peptide specifically designed to target glypican-3 (GPC3) with a dissociation constant (Kd) of 0.3 nM. This compound features a DOTA moiety, enabling labeling with radioactive elements for imaging and therapeutic applications. It is utilized in cancer research, particularly for the study of GPC3-expressing tumors, making it a valuable tool for targeted radiotherapy and diagnostic imaging strategies.
DOTA-GPC3 targeting peptide 2 is an RDC peptide specifically designed to target glypican-3 (GPC3) with a dissociation constant (Kd) of 0.3 nM. This compound features a DOTA moiety, enabling labeling with radioactive elements for imaging and therapeutic applications. It is utilized in cancer research, particularly for the study of GPC3-expressing tumors, making it a valuable tool for targeted radiotherapy and diagnostic imaging strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
